Therapy Areas: Devices
22 March 2019 - - US-based ophthalmic pharmaceutical company Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) has started patient dosing in its Phase 2 clinical trial designed in accordance with the require...
22 March 2019 - GenePOC Inc disclosed on Thursday the receipt of approval from the US FDA for the GenePOC Strep A assay to be used along with the revogene device.The Group A Streptococcus (GAS) infect...
22 March 2019 - Heart failure treatment company Impulse Dynamics reported on Thursday the receipt of approval from the US Food and Drug Administration for its first-in-class Optimizer Smart System des...
21 March 2019 - - US-based Aura Biosciences, a specialist in the development of novel targeted therapies in ocular oncology, will present interim clinical data from its Phase 1b/2 clinical trial evalu...
20 March 2019 - Medical device company Titan Medical Inc (TSX:TMD) (NASDAQ:TMDI) said on Tuesday that it has filed a final short form prospectus in connection with the marketed offering of units at a ...
20 March 2019 - Medical device company Soliton Inc (Nasdaq:SOLY) said on Tuesday that it has completed the human trials of its proprietary Rapid Acoustic Pulse (RAP) technology to accelerate tattoo fa...